ACNE TREATMENT WITH SULFUR- sulfur ointment 
DLC Laboratories, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Acne Treatment with 5% Sulfur

Drug Facts

Active ingredient

Sulfur, 5%

Purpose

Acne medication

Uses

for the treatment of acne

Warnings

For external use only

Do not use on

  • broken skin
  • large areas of the skin

When using this product

  • do not get into eyes
  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time or right after use of this product. If irritation occurs, only use one topical acne medication at a time.
  • apply only to areas with acne

Stop use and consult a doctor ifexcessive skin irritation develops or increases.

Keep out of the reach of children.If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Inactive ingredient

polyethylene glycol

Questions

1-800-858-3889

Manufactured by: De La Cruz Products
A Division of DLC Laboratories, Inc. | Paramount, CA 90723 USA

PRINCIPAL DISPLAY PANEL - 74 g Tube Label

De La Cruz ®

FOR SENSITIVE SKIN

ACNE
TREATMENT

With 5% Sulfur

OIL-FREE
WATER-WASHABLE

Ointment

2.6 OZ (74 g)

Acne treatment 5% sulfur

ACNE TREATMENT WITH SULFUR 
sulfur ointment
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:24286-1573
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SULFUR (UNII: 70FD1KFU70) (SULFUR - UNII:70FD1KFU70) SULFUR5 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)  
POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P)  
Product Characteristics
ColoryellowScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:24286-1573-174 g in 1 TUBE; Type 0: Not a Combination Product08/16/2019
2NDC:24286-1573-26 g in 1 JAR; Type 0: Not a Combination Product09/13/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart333D08/16/2019
Labeler - DLC Laboratories, Inc. (093351930)

Revised: 6/2023
Document Id: fea85a67-4e87-030e-e053-6294a90a89a3
Set id: aa1f2afe-7b09-4448-b522-e1b23d63d3ef
Version: 3
Effective Time: 20230621
 
DLC Laboratories, Inc.